author-photo

Maria Lagerström-Fermér

AstraZeneca

24

Papers

512

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (4)
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction

2020 Contemporary clinical trials communications
Show All
- Source
- Cite
- Save
Citations (1)
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction:Results from the PROMIS-HFpEF Study

2020 Circulation
Show All
- Source
- Cite
- Save
Citations (25)
Synthetic mRNA encoding VEGF-A in patients undergoing coronary artery bypass grafting: design of a phase 2a clinical trial

2020 Molecular therapy. Methods & clinical development
Show All
- Source
- Cite
- Save
Citations (21)
Early clinical experience with AZD4831, a novel myeloperoxidase inhibitor, developed for patients with heart failure with preserved ejection fraction.

2020 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (3)
Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability

2019 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (6)
PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve

2019 Vascular Health and Risk Management
Show All
- Source
- Cite
- Save
Citations (2)
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (56)
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction : PROMIS-HFpEF

2018 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (170)
Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor

2018 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (13)